Canaccord Genuity disclosed Consort Medical PLC (LON:CSRT), supporting its stock price target at 1,300.00GBX earlier today
- Updated: September 19, 2016
Showing a price of 1,065.50GBX, Consort Medical PLC (LON:CSRT) traded 0.09% higher on the day. The last stock close is up 4.31% from the two hundred day moving average, compared with the S&P 500 Index which has fallen -0.01% over the same period. CSRT has logged a 50-day average of 1,033.32GBX and two hundred day average of 1,017.17GBX. 755 shares of CSRT traded hands, down from ann avg. trading volume of 54,029
Stating a possible upside of 0.22%, Canaccord Genuity held the price target of Consort Medical PLC (LON:CSRT) at 1,300GBX
Previously on 8/11/2016, Canaccord Genuity released a statement for Consort Medical PLC(LON:CSRT) kept the target price at 1,300.00GBX. At the time, this indicated a possible upside of 0.31%.
A total of 7 equity analysts have released a report on Consort Medical PLC. Zero rate the stock a strong buy, 0 rate the stock a buy, 0 analysts rate the company a hold, 0 rate the stock to underperform, and finally 0 analystsrate the stock as sell with a consensus target of 1,129.71GBX
With a total market value of 0.0 GBX, Consort Medical PLC has a PE of 35 with a 52 week low of 904.20GBX and a one-year high of 1,155.00GBX.
General Company Details For Consort Medical PLC (LON:CSRT)
Consort Medical PLC is a contract development and manufacturing organization (CDMO). The Company’s principal activities include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica. Bespak’s core business is the manufacture of inhaled drug delivery devices for life sciences partners and its operations are based in the United Kingdom. The Aesica business manufactures and sells active pharmaceutical ingredients (API), formulated pharmaceutical products and packaging services to the pharmaceutical industry and its operations are based in the United Kingdom and Europe. It offers its services to customers, such as pharmaceutical companies and life sciences. Its device products include metered dose inhalers, dry powder devices, actuators, dose counters, disposable auto-injectors, and nasal devices and point-of-care diagnostics devices.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.